NurExone Biologic (NRX.V) Q2 2024 Earnings

29MayConfirmed
Q2 2023
Q2 2024
-0.03
-0.02
-0.02
-0.02

Details

Expected EPS
-0.0274346
Actual EPS
-0.0274346
Surprise EPS
0
Surprise Percent
+0%

Description

NurExone Biologic (NRX.V) has reported earnings of -0.0274346 per share for Q2 2024.

0 Comments

Share your thoughts